UnitedHealth Group (UNH) shares rallied over 5% on Thursday, snapping a five-day losing streak, after two major Wall Street analysts issued bullish notes that reinforced optimism about the health insurer's turnaround.
Bank of America upgraded the stock to Buy from Neutral and raised its price target to $450 from $420. Analyst Kevin Fischbeck pointed to improving medical cost trends, with Bank of America's Trend Tracker data indicating lower healthcare utilization in April and May. This is typically favorable for managed care companies' profitability. Fischbeck argued that UnitedHealth's strong first-quarter performance was not merely a temporary result of a weak flu season and storm disruptions, but rather a sign of underlying strength that could persist into the second quarter.
Morgan Stanley also raised its price target to $453 from $395 while maintaining an Overweight rating. Analyst Erin Wright highlighted the same moderating utilization trends and additionally cited potential earnings benefits from artificial intelligence. UnitedHealth plans to invest $1.5 billion in AI this year, expecting a two-to-one return, with Wright estimating AI-driven efficiencies could boost EPS by up to 45% in the long term.
The dual upgrades sent positive sentiment rippling across the managed care sector, lifting the State Street Health Care Select Sector SPDR ETF by 3.2% toward its largest single-day gain in over a year. The rally underscores Wall Street’s growing confidence that improving cost patterns and operational changes—including a strategic overhaul, membership reductions, and technology investments—are setting UnitedHealth up for a sustained recovery.
